Literature DB >> 30264261

[Carboplatin does not increase the effectiveness of adjuvant radiotherapy in advanced cutaneous squamous cell carcinoma of the head and neck region].

Robert Michael Hermann1, Hans Christiansen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30264261     DOI： 10.1007/s00066-018-1375-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Authors:  Jacques Bernier; Christian Domenge; Mahmut Ozsahin; Katarzyna Matuszewska; Jean-Louis Lefèbvre; Richard H Greiner; Jordi Giralt; Philippe Maingon; Frédéric Rolland; Michel Bolla; Francesco Cognetti; Jean Bourhis; Anne Kirkpatrick; Martine van Glabbeke
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

3.  Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy.

Authors:  Jeffrey T Wang; Carsten E Palme; Gary J Morgan; Val Gebski; Allen Y Wang; Michael J Veness
Journal:  Head Neck       Date:  2011-11-23       Impact factor: 3.147

4.  Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.

Authors:  Michael J Veness; Gary J Morgan; Carsten E Palme; Val Gebski
Journal:  Laryngoscope       Date:  2005-05       Impact factor: 3.325

5.  Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.

Authors:  Misha Amoils; Carolyn S Lee; John Sunwoo; Sumaira Z Aasi; Wendy Hara; Jinah Kim; Davud Sirjani; A Dimitrios Colevas; Anne Lynn S Chang; Vasu Divi
Journal:  Head Neck       Date:  2017-03-02       Impact factor: 3.147

6.  Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.

Authors:  David L Schwartz; R Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anzai; Raylene Canby; Raelene Buelna; Leslie Anderson; Charles Boyd; Janice Hutson; Kathryn Keegan
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

7.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Authors:  Joel Shapiro; J Jan B van Lanschot; Maarten C C M Hulshof; Pieter van Hagen; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W Ten Kate; Geert-Jan M Creemers; Cornelis J A Punt; John Th M Plukker; Henk M W Verheul; Ernst J Spillenaar Bilgen; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  Lancet Oncol       Date:  2015-08-05       Impact factor: 41.316
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.